Filing Details

Accession Number:
0001140361-15-034903
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-11 17:36:36
Reporting Period:
2015-09-10
Filing Date:
2015-09-11
Accepted Time:
2015-09-11 17:36:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1200375 Codexis Inc CDXS Industrial Organic Chemicals (2860) 710872999
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181179 J Bernard Kelley C/O Codexis, Inc.
200 Penobscot Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-10 16,666 $1.05 198,346 No 4 M Direct
Common Stock Disposition 2015-09-10 5,200 $3.45 193,146 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-09-10 16,666 $0.00 16,666 $1.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-10-18 No 4 M Direct
Footnotes
  1. The reporting person voluntarily exercised the stock option and sold shares sufficient to cover the exercise price to avoid the expiration of such option in October 2015.
  2. Includes 20,731 shares of restricted stock. Such shares vest on the earlier of June 10, 2016 or the date of the Issuer's 2016 annual meeting of stockholders.
  3. This transaction was executed in multiple trades in prices ranging from $3.45 to $3.50, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  4. 100% of the shares subject to the option are fully vested and exercisable.